1AD 0.00% 1.7¢ adalta limited

Ann: Investor webinar presentation, page-6

  1. 868 Posts.
    lightbulb Created with Sketch. 216
    Yes Beno very likely in the next few weeks a pharma company will offer you 3 x market cap for a share of revenue in a pre phase 2 asset that has absolutely no human efficacy data whatsoever. Sounds very very plausible.
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.